Meeting Banner
Abstract #2230

Longitudinal opto-pharmaco-fMRI of Selective Serotonin Reuptake Inhibition

Horea-Ioan Ioanas1,2, Bechara John Saab2, and Markus Rudin1

1Institute for Biomedical Engineering, ETH and University of Zurich, Zürich, Switzerland, 2Preclinical Laboratory for Translational Research into Affective Disorders, DPPP, Psychiatric Hospital, University of Zurich, Zürich, Switzerland

The serotonergic system is a high-centrality node in the brain network implicated in affective disorders and their treatment. We use optogenetics, fMRI, and pharmacology to image serotonergic effects of antidepressant treatment in mice at the whole-brain level. We stimulate the ascending serotonergic system and perform functional imaging at multiple time points over the course of antidepressant (fluoxetine) treatment. We establish the feasibility of this paradigm, and report two trends in serotonergic kinetics: (a) increased serotonergic system signal transmission upon acute, but not chronic fluoxetine administration, (b) decreased serotonergic system excitability during the first phase of chronic fluoxetine administration.

This abstract and the presentation materials are available to members only; a login is required.

Join Here